The probiotic compound VSL#3 modulates mucosal, peripheral, and systemic immunity following murine broad-spectrum antibiotic treatment

Frontiers in Cellular and Infection Microbiology

Volumn 7, Issue MAY, 2017, Pages

  Ekmekciu, Ira ^a   von Klitzing, Eliane ^a   Fiebiger, Ulrike ^a   Neumann, Christian ^a,b   Bacher, Petra ^a   Scheffold, Alexander ^a,b   Bereswill, Stefan ^a   Heimesaat, Markus M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b POTSDAM INSTITUTE FOR CLIMATE IMPACT RESEARCH PIK   (Germany)

Author keywords

Antibiotics; Fecal microbiota transplantation; Innate and adaptive immunity; Microbiota; Mucosal and peripheral and central immunity; Probiotics; Secondary abiotic (gnotobiotic) mice

Indexed keywords

ANTIINFECTIVE AGENT; CYTOKINE; PROBIOTIC AGENT;

ADAPTIVE IMMUNITY; ANIMAL; B LYMPHOCYTE; BACTERIUM; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLASSIFICATION; COLON; DENDRITIC CELL; DRUG COMBINATION; DRUG EFFECTS; FECES; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE; INTESTINE FLORA; INTESTINE MUCOSA; LYMPH NODE; METABOLISM; MICROBIOLOGY; MOUSE; REGULATORY T LYMPHOCYTE; SPLEEN; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; ANIMALS; ANTI-BACTERIAL AGENTS; B-LYMPHOCYTES; BACTERIA; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLON; CYTOKINES; DENDRITIC CELLS; DRUG COMBINATIONS; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; INTESTINES; LYMPH NODES; MICE; MICE, INBRED C57BL; PROBIOTICS; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 85027500208     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2017.00167     Document Type: Article

References (72)

1. Alberda, C., Gramlich, L., Meddings, J., Field, C., McCargar, L., Kutsogiannis, D., et al. (2007). Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Am. J. Clin. Nutr. 85, 816-823. Available online at: http://ajcn.nutrition.org/content/85/3/816.long
2. Alutis, M. E., Grundmann, U., Fischer, A., Hagen, U., Kuhl, A. A., Gobel, U. B., et al. (2015). The role of gelatinases in Campylobacter jejuni infection of gnotobiotic mice. Eur. J. Microbiol. Immunol. 5, 256-267. doi: 10.1556/1886.2015.00033
3. Antonelli, M., Moreno, R., Vincent, J. L., Sprung, C. L., Mendoca, A., Passariello, M., et al. (1999). Application of SOFA score to trauma patients. Sequential Organ Failure Assessment. Intensive Care Med. 25, 389-394. doi: 10.1007/s001340050863
4. Aujla, S. J., Dubin, P. J., and Kolls, J. K. (2007). Th17 cells and mucosal host defense. Semin. Immunol. 19, 377-382. doi: 10.1016/j.smim.2007.10.009
5. Backhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101, 15718-15723. doi: 10.1073/pnas.0407076101
6. Backhed, F., Manchester, J. K., Semenkovich, C. F., and Gordon, J. I. (2007). Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U.S.A. 104, 979-984. doi: 10.1073/pnas.0605374104
7. Barletta, B., Rossi, G., Schiavi, E., Butteroni, C., Corinti, S., Boirivant, M., et al. (2013). Probiotic VSL#3-induced TGF-beta ameliorates food allergy inflammation in a mouse model of peanut sensitization through the induction of regulatory T cells in the gut mucosa. Mol. Nutr. Food Res. 57, 2233-2244. doi: 10.1002/mnfr.201300028
8. Baumgart, D. C., and Carding, S. R. (2007). Inflammatory bowel disease: cause and immunobiology. Lancet 369, 1627-1640. doi: 10.1016/S0140-6736(07)60750-8
9. Becattini, S., Taur, Y., and Pamer, E. G. (2016). Antibiotic-induced changes in the intestinal microbiota and disease. Trends Mol. Med. 22, 458-478. doi: 10.1016/j.molmed.2016.04.003
10. Bereswill, S., Fischer, A., Plickert, R., Haag, L. M., Otto, B., Kuhl, A. A., et al. (2011). Novel murine infection models provide deep insights into the "Ménage à Trois" of Campylobacter jejuni, microbiota and host innate immunity. PLoS ONE 6:e20953. doi: 10.1371/annotation/5247af81-4595-44b7-9c3f-2e45ad85abfa
11. Bereswill, S., Munoz, M., Fischer, A., Plickert, R., Haag, L. M., Otto, B., et al. (2010). Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS ONE 5:e15099. doi: 10.1371/journal.pone.0015099
12. Bernet-Camard, M. F., Lievin, V., Brassart, D., Neeser, J. R., Servin, A. L., and Hudault, S. (1997). The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl. Environ. Microbiol. 63, 2747-2753
13. Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., et al. (2008). Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371, 651-659. doi: 10.1016/S0140-6736(08)60207-X
14. Carding, S., Verbeke, K., Vipond, D. T., Corfe, B. M., and Owen, L. J. (2015). Dysbiosis of the gut microbiota in disease. Microb. Ecol. Health Dis. 26:26191. doi: 10.3402/mehd.v26.26191
15. Carroll, I. M., Chang, Y. H., Park, J., Sartor, R. B., and Ringel, Y. (2010). Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog. 2:19. doi: 10.1186/1757-4749-2-19
16. Cebra, J. J. (1999). Influences of microbiota on intestinal immune system development. Am. J. Clin. Nutr. 69, 1046s-1051s
17. Cording, S., Fleissner, D., Heimesaat, M. M., Bereswill, S., Loddenkemper, C., Uematsu, S., et al. (2013). Commensal microbiota drive proliferation of conventional and Foxp3+ regulatory CD4+ T cells in mesenteric lymph nodes and Peyer's patches. Eur. J. Microbiol. Immunol. 3, 1-10. doi: 10.1556/EuJMI.3.2013.1.1
18. Dalhoff, A., and Shalit, I. (2003). Immunomodulatory effects of quinolones. Lancet Infect. Dis. 3, 359-371. doi: 10.1016/S1473-3099(03)00658-3
19. De Palma, G., Nadal, I., Medina, M., Donat, E., Ribes-Koninckx, C., Calabuig, M., et al. (2010). Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children. BMC Microbiol. 10:63. doi: 10.1186/1471-2180-10-63
20. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W., and Boirivant, M. (2005). Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β-bearing regulatory cells. J. Immunol. 174, 3237-3246. doi: 10.4049/jimmunol.174.6.3237
21. FAO/WHO (2002). Guidelines for the Evaluation of Probiotics in Food. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. Available online at: ftp://ftp.fao.org/es/esn/food/wgreport2.pdf (Accessed)
22. Fiebiger, U., Bereswill, S., and Heimesaat, M. M. (2016). Dissecting the interplay between intestinal microbiota and host immunity in health and disease: lessons learned from germfree and gnotobiotic animal models. Eur. J. Microbiol. Immunol. 6, 253-271. doi: 10.1556/1886.2016.00036
23. Galdeano, C. M., and Perdigon, G. (2006). The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vaccine Immunol. 13, 219-226. doi: 10.1128/CVI.13.2.219-226.2006
24. Gionchetti, P., Rizzello, F., Helwig, U., Venturi, A., Lammers, K. M., Brigidi, P., et al. (2003). Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124, 1202-1209. doi: 10.1016/S0016-5085(03)00171-9
25. Gopal, P. K., Prasad, J., Smart, J., and Gill, H. S. (2001). In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidobacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Escherichia coli. Int. J. Food Microbiol. 67, 207-216. doi: 10.1016/S0168-1605(01)00440-8
26. Grabig, A., Paclik, D., Guzy, C., Dankof, A., Baumgart, D. C., Erckenbrecht, J., et al. (2006). Escherichia coli strain Nissle 1917 Ameliorates experimental colitis via toll-like receptor 2-and toll-like receptor 4-dependent pathways. Infect. Immun. 74, 4075-4082. doi: 10.1128/IAI.01449-05
27. Haag, L. M., Fischer, A., Otto, B., Plickert, R., Kuhl, A. A., Gobel, U. B., et al. (2012). Campylobacter jejuni induces acute enterocolitis in gnotobiotic IL-10-/-mice via Toll-like-receptor-2 and-4 signaling. PLoS ONE 7:e40761. doi: 10.1371/journal.pone.0040761
28. Hassoun, H. T., Kone, B. C., Mercer, D. W., Moody, F. G., Weisbrodt, N. W., and Moore, F. A. (2001). Post-injury multiple organ failure: the role of the gut. Shock 15, 1-10. doi: 10.1097/00024382-200115010-00001
29. Heimesaat, M. M., Bereswill, S., Fischer, A., Fuchs, D., Struck, D., Niebergall, J., et al. (2006). Gram-negative bacteria aggravate murine small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii. J. Immunol. 177, 8785-8795. doi: 10.4049/jimmunol.177.12.8785
30. Heimesaat, M. M., Boelke, S., Fischer, A., Haag, L. M., Loddenkemper, C., Kuhl, A. A., et al. (2012). Comprehensive postmortem analyses of intestinal microbiota changes and bacterial translocation in human flora associated mice. PLoS ONE 7:e40758. doi: 10.1371/journal.pone.0040758
31. Heimesaat, M. M., Dunay, I. R., Alutis, M., Fischer, A., Mohle, L., Gobel, U. B., et al. (2014). Nucleotide-oligomerization-domain-2 affects commensal gut microbiota composition and intracerebral immunopathology in acute Toxoplasma gondii induced murine ileitis. PLoS ONE 9:e105120. doi: 10.1371/journal.pone.0105120
32. Heimesaat, M. M., Fischer, A., Siegmund, B., Kupz, A., Niebergall, J., Fuchs, D., et al. (2007). Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via Toll-like receptors 2 and 4. PLoS ONE 2:e662. doi: 10.1371/journal.pone.0000662
33. Heimesaat, M. M., Nogai, A., Bereswill, S., Plickert, R., Fischer, A., Loddenkemper, C., et al. (2010). MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut 59, 1079-1087. doi: 10.1136/gut.2009.197434
34. Hill, D. A., and Artis, D. (2010). Intestinal bacteria and the regulation of immune cell homeostasis. Annu. Rev. Immunol. 28, 623-667. doi: 10.1146/annurev-immunol-030409-101330
35. Hooper, L. V., Midtvedt, T., and Gordon, J. I. (2002). How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 22, 283-307. doi: 10.1146/annurev.nutr.22.011602.092259
36. Hudault, S., Lievin, V., Bernet-Camard, M. F., and Servin, A. L. (1997). Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl. Environ. Microbiol. 63, 513-518
37. Husebye, E., Hellstrom, P. M., and Midtvedt, T. (1994). Intestinal microflora stimulates myoelectric activity of rat small intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex. Dig. Dis. Sci. 39, 946-956. doi: 10.1007/BF02087542
38. Jijon, H., Backer, J., Diaz, H., Yeung, H., Thiel, D., McKaigney, C., et al. (2004). DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126, 1358-1373. doi: 10.1053/j.gastro.2004.02.003
39. Jonkers, D., Penders, J., Masclee, A., and Pierik, M. (2012). Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs 72, 803-823. doi: 10.2165/11632710-000000000-00000
40. Kamada, N., Inoue, N., Hisamatsu, T., Okamoto, S., Matsuoka, K., Sato, T., et al. (2005). Nonpathogenic Escherichia coli strain Nissle 1917 prevents murine acute and chronic colitis. Inflamm. Bowel Dis. 11, 455-463. doi: 10.1097/01.MIB.0000158158.55955.de
41. Kanoh, S., and Rubin, B. K. (2010). Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin. Microbiol. Rev. 23, 590-615. doi: 10.1128/CMR.00078-09
42. Kruis, W., Fric, P., Pokrotnieks, J., Lukas, M., Fixa, B., Kascak, M., et al. (2004). Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53, 1617-1623. doi: 10.1136/gut.2003.037747
43. Kwon, H. K., Lee, C. G., So, J. S., Chae, C. S., Hwang, J. S., Sahoo, A., et al. (2010). Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc. Natl. Acad. Sci. U.S.A. 107, 2159-2164. doi: 10.1073/pnas.0904055107
44. LeBlanc, J. G., Milani, C., de Giori, G. S., Sesma, F., van Sinderen, D., and Ventura, M. (2013). Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr. Opin. Biotechnol. 24, 160-168. doi: 10.1016/j.copbio.2012.08.005
45. Mann, E. R., Bernardo, D., English, N. R., Landy, J., Al-Hassi, H. O., Peake, S. T., et al. (2016). Compartment-specific immunity in the human gut: properties and functions of dendritic cells in the colon versus the ileum. Gut 65, 256-270. doi: 10.1136/gutjnl-2014-307916
46. McCarville, J. L., Caminero, A., and Verdu, E. F. (2016). Novel perspectives on therapeutic modulation of the gut microbiota. Therap. Adv. Gastroenterol. 9, 580-593. doi: 10.1177/1756283X16637819
47. Munoz, M., Heimesaat, M. M., Danker, K., Struck, D., Lohmann, U., Plickert, R., et al. (2009). Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. J. Exp. Med. 206, 3047-3059. doi: 10.1084/jem.20090900
48. Noverr, M. C., and Huffnagle, G. B. (2004). Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 12, 562-568. doi: 10.1016/j.tim.2004.10.008
49. Ochoa-Reparaz, J., Mielcarz, D. W., Ditrio, L. E., Burroughs, A. R., Foureau, D. M., Haque-Begum, S., et al. (2009). Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol. 183, 6041-6050. doi: 10.4049/jimmunol.0900747
50. Pagnini, C., Saeed, R., Bamias, G., Arseneau, K. O., Pizarro, T. T., and Cominelli, F. (2009). Probiotics promote gut health through stimulation of epithelial innate immunity. Proc. Natl. Acad. Sci. U.S.A. 107, 454-459. doi: 10.1073/pnas.0910307107
51. Potten, C. S., Booth, C., and Pritchard, D. M. (1997). The intestinal epithelial stem cell: the mucosal governor. Int. J. Exp. Pathol. 78, 219-243. doi: 10.1046/j.1365-2613.1997.280362.x
52. Quigley, E. M., and Quera, R. (2006). Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 130(2 Suppl. 1), S78-S90. doi: 10.1053/j.gastro.2005.11.046
53. Rausch, S., Held, J., Fischer, A., Heimesaat, M. M., Kuhl, A. A., Bereswill, S., et al. (2013). Small intestinal nematode infection of mice is associated with increased enterobacterial loads alongside the intestinal tract. PLoS ONE 8:e74026. doi: 10.1371/journal.pone.0074026
54. Reikvam, D. H., Erofeev, A., Sandvik, A., Grcic, V., Jahnsen, F. L., Gaustad, P., et al. (2011). Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS ONE 6:e17996. doi: 10.1371/journal.pone.0017996
55. Scholzen, T., and Gerdes, J. (2000). The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 182, 311-322. doi: 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9
56. Schultz, M., Veltkamp, C., Dieleman, L. A., Grenther, W. B., Wyrick, P. B., Tonkonogy, S. L., et al. (2002). Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis. 8, 71-80. doi: 10.1097/00054725-200203000-00001
57. Sekirov, I., Tam, N. M., Jogova, M., Robertson, M. L., Li, Y., Lupp, C., et al. (2008). Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 76, 4726-4736. doi: 10.1128/IAI.00319-08
58. Selinger, C. P., Bell, A., Cairns, A., Lockett, M., Sebastian, S., and Haslam, N. (2013). Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial. J. Hosp. Infect. 84, 159-165. doi: 10.1016/j.jhin.2013.02.019
59. Serino, M., Blasco-Baque, V., Nicolas, S., and Burcelin, R. (2014). Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences. Curr. Cardiol. Rep. 16:540. doi: 10.1007/s11886-014-0540-1
60. Shen, B., and Lashner, B. A. (2008). Diagnosis and treatment of pouchitis. Gastroenterol. Hepatol. (N.Y). 4, 355-361
61. Shen, J., Zuo, Z. X., and Mao, A. P. (2014). Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm. Bowel Dis. 20, 21-35. doi: 10.1097/01.MIB.0000437495.30052.be
62. Sheridan, B. S., and Lefrancois, L. (2012). Isolation of mouse lymphocytes from small intestine tissues. Curr. Protoc. Immunol. Chapter 3:Unit3.19. doi: 10.1002/0471142735.im0319s99
63. Smelt, M. J., de Haan, B. J., Bron, P. A., van Swam, I., Meijerink, M., Wells, J. M., et al. (2013). Probiotics can generate FoxP3 T-cell responses in the small intestine and simultaneously inducing CD4 and CD8 T cell activation in the large intestine. PLoS ONE 8:e68952. doi: 10.1371/journal.pone.0068952
64. Sprent, J., and Surh, C. D. (2002). T cell memory. Annu. Rev. Immunol. 20, 551-579. doi: 10.1146/annurev.immunol.20.100101.151926
65. Stappenbeck, T. S., Hooper, L. V., and Gordon, J. I. (2002). Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc. Natl. Acad. Sci. U.S.A. 99, 15451-15455. doi: 10.1073/pnas.202604299
66. Taurog, J. D., Richardson, J. A., Croft, J. T., Simmons, W. A., Zhou, M., Fernandez-Sueiro, J. L., et al. (1994). The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180, 2359-2364. doi: 10.1084/jem.180.6.2359
67. Thoene-Reineke, C., Fischer, A., Friese, C., Briesemeister, D., Gobel, U. B., Kammertoens, T., et al. (2014). Composition of intestinal microbiota in immune-deficient mice kept in three different housing conditions. PLoS ONE 9:e113406. doi: 10.1371/journal.pone.0113406
68. Ukena, S. N., Singh, A., Dringenberg, U., Engelhardt, R., Seidler, U., Hansen, W., et al. (2007). Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE 2:e1308. doi: 10.1371/journal.pone.0001308
69. Wagner, R. D., Johnson, S. J., and Kurniasih Rubin, D. (2009). Probiotic bacteria are antagonistic to Salmonella enterica and Campylobacter jejuni and influence host lymphocyte responses in human microbiota-associated immunodeficient and immunocompetent mice. Mol. Nutr. Food Res. 53, 377-388. doi: 10.1002/mnfr.200800101
70. Wallet, M. A., Sen, P., and Tisch, R. (2005). Immunoregulation of dendritic cells. Clin. Med. Res. 3, 166-175. doi: 10.3121/cmr.3.3.166
71. Wassenaar, T. M. (2016). Insights from 100 years of research with probiotic E. Coli. Eur. J. Microbiol. Immunol. 6, 147-161. doi: 10.1556/1886.2016.00029
72. Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., et al. (2008). Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455, 1109-1113. doi: 10.1038/nature07336